PharmaShots Weekly Snapshot (March 16-20, 2020)

1. Merck Collaborates with Dragonfly to Develop and Commercialize Novel Therapies Utilizing TriNKET Platform

Published: Mar 19, 2020 | Tags: Merck, Collaborates, Dragonfly, Develop, Commercialize, Novel Therapies, Utilizing, TriNKET Platform

2.  BGI Reports the Availability of RT-PCR SARS-CoV-2 Test for Clinical Use in the US

Published: Mar 20, 2020 | Tags: BGI, Reports, Availability, RT-PCR, SARS-CoV-2 Test, Clinical Use, US

3.  FDA Recommends Avoiding the Use of NSAIDs for COVID-19 Symptoms

Published: Mar 19, 2020 | Tags: FDA, Recommends, Avoiding, Use, NSAIDs, COVID-19 Symptoms

4. Abbott Launches its Molecular Test to Detect COVID-19 and Receives the US FDA’s Emergency Use Authorization

Published: Mar 18, 2020 | Tags: Abbott, Launches, Molecular Test, Detect, COVID-19, Receives, US, FDA, Emergency Use Authorization

5.  Gilead’s Epclusa (Sofosbuvir/Velpatasvir) Receives the US FDA’s Approval for Children with Chronic Hepatitis C Infection

Published: Mar 19, 2020 | Tags: Gilead, Epclusa, Sofosbuvir/Velpatasvir, Receives, US, FDA, Approval, Children, Chronic Hepatitis C Infection

6.  CEPI Collaborates with University of Hong Kong to Develop Vaccine for COVID-19

Published: Mar 18, 2020 | Tags: CEPI, Collaborates, University of Hong Kong, Develop, Vaccine, COVID-19

7. Janssen Reports Submission of Ponesimod’s NDA to the US FDA for the Treatment of Relapsing Multiple Sclerosis

Published: Mar 18, 2020 | Tags: Janssen, Reports, Submission, Ponesimod, NDA, US, FDA, Treatment, Relapsing, Multiple Sclerosis

8. FDA Divulges Guidance for Conducting Clinical Studies During COVID-19 Pandemic

Published: Mar 17, 2020 | Tags: FDA, Divulges, Guidance, Conducting, Clinical Studies, During, COVID-19 Pandemic

9. AstraZeneca’s Lynparza (olaparib) Receives MHLW’s Orphan Drug Designation for BRCA-Mutated Metastatic Pancreatic Cancer

Published: Mar 19, 2020 | Tags: AstraZeneca, Lynparza, olaparib, Receives, MHLW, Orphan Drug Designation, BRCA-Mutated, Metastatic Pancreatic Cancer

10. Eli Lilly and ISDH Collaborate to Accelerate the Testing for COVID-19

Published: Mar 18, 2020 | Tags: Eli Lilly, ISDH, Collaborate, Accelerate, Testing, COVID-19

11. Novartis’ Zolgensma (onasemnogene abeparvovec) Receives MHLW’s Approval for Spinal Muscular Atrophy

Published: Mar 19, 2020 | Tags: Novartis, Zolgensma, onasemnogene abeparvovec, Receives, MHLW, Approval, Spinal Muscular Atrophy

12. Roche to Initiate P-III COVACTA Study of Actemra/RoActemra in Hospitalized Patients with Severe Covid-19 Pneumonia in Collaboration with BARDA

Published: Mar 19, 2020 | Tags: Roche, Initiate, P-III, COVACTA Study, Actemra/RoActemra, Hospitalized Patients, Severe, Covid-19 Pneumonia, BARDA

13. Juno Therapeutics Signs License and Clinical Supply Agreement with Oxford Biomedica for LentiVector Platform

Published:  Mar 18, 2020 | Tags: Juno Therapeutics, Signs, License Agreement, Oxford Biomedica, LentiVector Platform

14. Samsung Biologics Collaborates with APRINOIA Therapeutics to Expand its Presence in Greater China

Published: Mar 16, 2020 | Tags: Samsung Biologics, Collaborates, APRINOIA Therapeutics, Expand, Presence, Greater China

15.  IDEAYA and Pfizer Collaborate to Evaluate IDE196 + Binimetinib in Solid Tumors Harboring GNAQ or GNA11 Hotspot Mutations

Published: Mar 18, 2020 | Tags: IDEAYA, Pfizer, Collaborate, Evaluate, IDE196, Binimetinib, Solid Tumors, Harboring, GNAQ, GNA11, Hotspot Mutations

16.  Regeneron to Initiate COVID-19 Antibody Program in Early Summer

Published: Mar 17, 2020 | Tags: Regeneron, Initiate, COVID-19, Antibody Program, Early Summer

17. NuProbe Collaborates with QIAGEN to Develop Diagnostics Tests for Cancer Indications

Published: Mar 16, 2020 | Tags: NuProbe, Collaborates, QIAGEN, Develop, Diagnostics Tests, Cancer Indications

18. Merck & Co. Reports Results of Gefapixant (MK-7264) in Two P-III Studies for Refractory or Unexplained Chronic Cough

Published: Mar 17, 2020 | Tags: Merck & Co., Reports, Results, Gefapixant, MK-7264, Two, P-III Studies, Refractory, Unexplained, Chronic Cough

19. Moleculin Collaborates with UTMB to Evaluate WP1122 for Multiple Viruses Including Coronavirus

Published: Mar 17, 2020 | Tags:  Moleculin, Collaborates, UTMB, Evaluate, WP1122, Multiple Viruses, Coronavirus

20. NIH Initiates its P-I Trial for COVID-19 at KPWHRI in Seattle

Published: Mar 16, 2020 | Tags:  Novo Nordisk, Fiasp, insulin aspart injection, Receives, Health Canada, Approval, Children, Diabetes

21.  GSK’s Nucala Receives Health Canada’s Approval for Severe Eosinophilic Asthma in Children and Adolescents

Published: Mar 16, 2020 | Tags: GSK, Nucala, Receives, Health Canada, Approval, Severe Eosinophilic Asthma, Children, Adolescents

22. Alphabet’s Verily Launched its COVID-19 Screening Site in Collaboration with California’s Government

Published: Mar 16, 2020 | Tags: Alphabet, Verily, Launch, COVID-19, Screening Site, Collaboration, California Governor 

23.  AstraZeneca Reports Results of Imfinzi + Tremelimumab in P-III CASPIAN Study as 1L Treatment for Extensive-Stage Small Cell Lung Cancer

Published: Mar 17, 2020 | Tags: AstraZeneca, Reports, Results, Imfinzi, Tremelimumab, P-III, CASPIAN, Study, 1L, Treatment, Extensive-Stage Small Cell Lung Cancer

24.  AcelRx to Acquire Tetraphase Pharmaceuticals to Expand its Product Portfolio

Published: Mar 16, 2020 | Tags: AcelRx, Acquire, Tetraphase Pharmaceuticals, Expand, Product Portfolio

25. Novo Nordisk Halts Clinical Studies Evaluating Concizumab (anti-TFPI mAb) for Hemophilia A and B With or Without Inhibitors

Published: Mar 17, 2020 | Tags: Novo Nordisk, Halts, Clinical Studies, Evaluating, Concizumab, (anti-TFPI mAb), Hemophilia A and B, With or Without Inhibitors

26. Pfizer and BioNTech Collaborate to Co-Develop BNT162 Against COVID-19

Published: Mar 17, 2020 | Tags: Pfizer, BioNTech, Collaborate, Co-Develop, BNT162, Against, COVID-19

27.  Teva and Celltrion Launch Herzuma (biosimilar, trastuzumab) in the US

Published: Mar 17, 2020 | Tags: Teva, Celltrion, Launch, Herzuma, biosimilar, trastuzumab, US

28. Sanofi and Regeneron to Initiate the Clinical Program Evaluating Kevzara (sarilumab) in Patients with Severe COVID-19

Published: Mar 16, 2020 | Tags: Sanofi, Regeneron, Initiate, Clinical Program, Evaluating, Kevzara, sarilumab, Patients, Severe, COVID-19

29. Biogen Collaborates with Vir Biotechnology to Develop Antibodies Against COVID-19

Published: Mar 12, 2020 | Tags: Biogen, Collaborates, Vir Biotechnology, Develop, Antibodies, Against, COVID-19

30. Eli Lilly and Incyte’s Olumiant (baricitinib) Receives the US FDA’s Breakthrough Therapy Designation for Alopecia Areata

Published: Mar 16, 2020 | Tags: Eli Lilly, Incyte, OLUMIANT, baricitinib, Receives, US, FDA, Breakthrough Therapy Designation, Alopecia Areata

31.  Fosun Pharma Signs an Agreement with BioNTech to Develop and Commercialize BNT162 for COVID-19

Published: Mar 16, 2020 | Tags: Fosun Pharma, Signs, Agreement, BioNTech, Develop, Commercialize, BNT162, COVID-19

32. Johnson & Johnson Collaborates with the Beth Israel Deaconess Medical Center to Accelerate the Development of Vaccine Against COVID-19

Published: Mar 13, 2020 | Tags: Johnson & Johnson, Collaborates, the Beth Israel Deaconess Medical Center, Accelerate, Development, Vaccine, Against, COVID-19

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post